CLOSE X

LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin
BSE1952.058.6 (+0.44 %)
PREV CLOSE ( ) 1943.45
OPEN PRICE ( ) 1944.05
BID PRICE (QTY) 1950.75 (6)
OFFER PRICE (QTY) 1952.00 (60)
VOLUME 11014
TODAY'S LOW / HIGH ( )1935.00 1961.05
52 WK LOW / HIGH ( )1531.15 2403.45
NSE1950.106.1 (+0.31 %)
PREV CLOSE( ) 1944.00
OPEN PRICE ( ) 1944.00
BID PRICE (QTY) 1950.10 (2402)
OFFER PRICE (QTY) 1950.50 (339)
VOLUME 790447
TODAY'S LOW / HIGH( ) 1932.50 1960.90
52 WK LOW / HIGH ( )1543 2402.9
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1983
Management Info
Manju D Gupta - Chairman Nilesh Gupta - Managing Director
Registered Office

Address Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone 022 66402323

Email info@lupin.com

Website www.lupin.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
16Jun Lupin signs license and supply agreeme
Lupin has signed a license and supply agreement with Sino Universal Phar..
16Jun Lupin moves up on signing license and
Lupin is currently trading at Rs. 2009.00, up by 8.65 points or 0.43% fr..
16Jun Lupin informs about press release
Lupin has informed that it enclosed a Press Release as regards, the Comp..
16Jun Lupin informs about press release
Lupin has informed that it enclosed a Press Release as regards, the Comp..
09Jun Lupin gets USFDA’s approval for Oxcarb
Lupin has received tentative approval from the United States Food and Dr..
Financials
in Millions
QTR Mar 25 ANNUAL 25
Net Profit12913.539729.6
Gross Profit 15530.9 48371.2
Operating Profit 17949.256465.3
Net Sales 44856.7169675
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Procter&Gamble Healt (BSE)
up  5954.65 (0.81%)
M.Cap ( in Cr)9892.90
Onesource Specialty (BSE)
up  2195.10 (1.61%)
M.Cap ( in Cr)25172.22
Divi's Lab (BSE)
up  6570.50 (0.51%)
M.Cap ( in Cr)174426.13
Mercury Laboratories (BSE)
up  849.90 (3.60%)
M.Cap ( in Cr)101.99
Aarti Pharmalabs (BSE)
up  887.90 (3.44%)
M.Cap ( in Cr)8043.37
Shareholding Pattern
PROMOTERS 46.92%
MUTUAL FUNDS/UTI 17.55%
FI/BANKS/INSURANCE 6.34%
NON-INSTITUTION 6.2%
GOVERNMENT 0.01%
FII 0%
Mf Holdings
Scheme NameHold(%)
Tata Nifty MidSmall Healthcare Index Fund-Reg(G)8.90
Motilal Oswal Nifty MidSmall Healthcare Index Fund-Reg(G)8.88
Nippon India Pharma Fund(G)7.27
Nippon India Nifty Pharma ETF6.52
ICICI Pru Nifty Pharma Index Fund-Reg(G)6.48
Mirae Asset Healthcare Fund-Reg(G)6.20
ITI Pharma & Healthcare Fund-Reg(G)5.78
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors